- Home
- ME
as 12-27-2024 2:39pm EST
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 113.9M | IPO Year: | N/A |
| Target Price: | $9.40 | AVG Volume (30 days): | 270.4K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -24.95 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.65 - $19.34 | Next Earning Date: | 02-05-2025 |
| Revenue: | $193,260,000 | Revenue Growth: | -28.47% |
| Revenue Growth (this year): | 21.93% | Revenue Growth (next year): | 17.31% |
Latest 23andMe Holding Co. News
ME Breaking Stock News: Dive into ME Ticker-Specific Updates for Smart Investing
Pharma Voice
18 days ago
What’s Next for 23andMe?
Simply Wall St.
25 days ago
US Penny Stocks: 3 Picks With Market Caps Under $200M
Insider Monkey
a month ago
Do Redditors Think That 23andMe Holding Co. (ME) Has a Big Upside Potential?
MT Newswires
a month ago
23andMe, Mirador Therapeutics Collaborate on Target Validation, Precision Medicine
GlobeNewswire
a month ago
23andMe and Mirador Therapeutics Enter Into Strategic Research Collaboration to Advance Mirador’s Precision Medicines for Immunology & Inflammation
MedTech Dive
a month ago
23andMe to lay off more than 200 employees amid business struggles
GuruFocus.com
a month ago
23andMe Holding Co (ME) Q2 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
Thomson Reuters StreetEvents
a month ago
Q2 2024 23andMe Holding Co. Earnings Call
Compare ME vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ME 23andMe Holding Co. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.